Dr. sc. Marina Šagud
Klinika za Psihijatriju
Medicinskog Fakulteta Sveučilišta u Zagrebu , KBC Zagreb
Životopis
Rođena sam u Zagrebu, gdje sam završila osnovnu školu i gimnaziju te diplomirala 1988. na Medicinskom fakultetu Sveučilišta u Zagrebu.
Nakon odrađenog pripravničkog staža 1989-1990, radila sam u farmaceutskoj kući „Pliva“ od 1991. do 1993. Od 1993 do 1997. sam bila specijalizant psihijatrije u Klinici za Psihijatriju, KBC Zagreb. Od 1997. sam specijalist psihijatar u Klinici za Psihijatriju, KBC Zagreb. Doktorsku disertaciju pod naslovom: Trombocitni serotonin, trombocitna MAO i serumski lipidi u dijagnostici i liječenju poremećaja raspoloženja, pod mentorstvom prof. dr. sc. Alme Mihaljević-Peleš obranila sam 2007.
Od 2008. sam viši asistent, a od 2012 docent, na katedri za psihijatriju i psihološku medicinu Medicinskog fakulteta sveučilišta u Zagrebu. Također sam tajnica i koordinator za e-učenje katedre za psihijatriju i psihološku medicinu Medicinskog fakulteta sveučilišta u Zagrebu. Od studenog 2011. sam voditelj odjela intenzivne njege Zavoda za afektivne poremećaje
Sudjelujem kao istraživač u kliničkim studijama, kao i u nekoliko Projekata Ministarstva znanosti u Klinici za psihijatriju KBC Zagreb i Institutu Ruđer Bošković.
Moj svakodnevni rad uključuje skrb za bolesnike na zatvorenom i otvorenom dijelu odjela za afektivne poremećaje, nastavu na dodiplomskom studiju medicinskog fakulteta sveučilišta u Zagrebu, diplomskom studiju sestrinstva, doktorskom studiju biomedicina i zdravstvo, stručnom poslijediplomskom specijalističkom studiju iz psihijatrije, te tečajevima stalnog usavršavnja liječnika.
Član sam Povjerenstva za lijekove KBC Zagreb, Hrvatskog psihijatrijskog društva.
Hrvatskog/svjetskog društva za biologijsku psihijatriju te Hrvatskog/svjetskog društva farmakologa, te sam član upravnog vijeća Hrvatskog društva za zaštitu osoba s intelektualniim teškoćama.
Popis publikacija:
Radovi objavljeni u: current contents:
- Vuksan-Cusa B, Sagud M, Jakovljevic M, Peles AM, Jaksic M, Mihaljevic S, Zivkovic M, Mikulic SK, Jevtovic S (2012)nAssociation between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia. Nord J Psychiatry, u tisku
- Nikolac M, Sagud M, Nedic G, Nenadic Sviglin K, Mihaljevic Peles A, Uzun S, Kozumplik O, Zivkovic M, Mustapic M, Jakovljevic M, Pavlovic M, Muck Seler D, Borovecki F, Pivac N (2012) Lack of association catechol-O-methyl transferase Val158/150 Met polymorphism and smoking in schizophrenia and alcohol dependence. Psychiatry Res, u tisku
- Sagud M, Nikolac M, Mihaljevic-Peles A, Nedic G, Vuksan Cusa B, Mustapic M, Jakovljevic M, Muck-Seler D, Pivac N (2012) The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients. Psychopharmacology, 219(4):1179-81
- Mück-Seler D, Sagud M, Mihaljevi-Peles A, Jakovljevi M, Pivac N (2011) Baseline lipid levels and acute treatment response to paroxetine and tianeptine in depressed women. J Clin Psychopharmacol 31(3):387-90
- Vuksan-Ćusa B, Jakovljević M, Sagud M, Mihaljević Peleš A, Marčinko D, Topić R, Mihaljević S, Sertić J (2011) Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics. Psychiatry Res 189(1):21-5
- Sagud M, Mihaljevic-Peles A, Pivac N, Jakovljevic M, Muck-Seler D. Lipid levels in female patients with affective disorders. Psychiatry Res. 2009 15;168(3):218-21
- Mihaljevic Peles A, Bozina N, Sagud M, Rojnic Kuzman M, Lovric M. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1439-44
- Muck-Seler D, Sagud M, Mustapic M, Nedic G, Babic A, Mihaljevic Peles A, Jakovljevic M, Pivac N. The effect of lamotrigine on platelet monoamine oxidase type B activity in patients with bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1195-1198
- Sagud M, Pivac N, Mueck-Šeler D, Jakovljevic M, Mihaljevic-Peles A, Korsic M (2002) Effects of sertraline on plasma cortisol, prolactin and thyroid hormones in female depressed patients. Neuropsychobiology 45 (3): 139-143
- Sagud M, Pivac N, Mustapic M, Nedic G, Peles AM, Kramaric M, Jakovljevic M, Muck-Seler D. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression. Psychopharmacology (Berl). 2008 May;197(4):683-685
- Bozina N, Peles AM, Sagud M, Bilusic H, Jakovljevic M. Association study of paroxetine therapeutic response with SERT gene polymorphisms in patients with major depressive disorder. World J Biol Psychiatry. 2008;9(3):190-197
- Sagud M, Mihaljević-Peleš A, Pivac N, Jakovljevic M, Muck-Seler D. Platelet serotonin and serum lipids in psychotic mania., J Affect Disord. 2007 Jan;97(1-3):247-51
- Sagud M, Mihaljević-Peleš A, Muck-Seler D, Jakovljevic M, Pivac N. Quetiapine augmentation in treatment-resistant depression: a naturalistic study. Psychopharmacology (Berl). 2006 Sep;187 (4):511-512
- Muck-Seler D, Pivac N, Mustapic M, Crncevic Z, Jakovljevic M, Sagud M.Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women., Psychiatry Res. 2004 Jul 15;127(3):217-26.
- Barisic I, Pivac N, Muck-Seler D, Jakovljevic M, Sagud M. Comorbid depression and platelet serotonin in hemodialysis patients.
Nephron Clin Pract. 2004;96(1):c10-4. - Pivac N, Muck-Seler D, Sagud M, Jakovljevic M, Mustapic M, Mihaljevic-Peles A. Long-term sertraline treatment and peripheral biochemical markers in female depressed patients., Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):759-65.
- Muck-Seler D, Pivac N, Jakovljevic M, Sagud M, Mihaljevic-Peles A. Platelet 5-HT concentration and comorbid depression in war veterans with and without posttraumatic stress disorder. J Affect Disord. 2003 Jul;75(2):171-9.
- Jakovljevic M, Sagud M, Mihaljevic-Peles A. Olanzapine in the treatment-resistant, combat-related PTSD–a series of case reports. Acta Psychiatr Scand. 2003 May;107(5):394-6; discussion 396.
- Hotujac Lj, Sagud M (2002) Efficacy and safety of long-term risperdone treatment. Int J Psychiatry Clin Practice 6 (4): 193-197
- Mück-eler D, Pivac N, Sagud M, Jakovljevi M, Mihaljevic-Peles A (2002) The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression. Progress in Neuropsychopharmacology & Biol Psychiatry 26(7-8):1235-1243.
- Mück-eler D, Pivac N, Sagud M, Jakovljevi M (2002) Platelet serotonin markers in posttraumatic stress disorder. Progress in Neuropsychopharmacology & Biol Psychiatry 26 (6): 1193-1198
- Sagud M, Hotujac Lj, Mihaljevic-Peles A, Jakovljevic M (2002) Gender differences in depression. Coll Antropol 26 (1): 149-157
- Mihaljevic-Peles A, Jakovljevic M, Mrsic M, Sagud M (2001) Trombocytopenia associated with clozapine and fluphenazine. Nord J Psychiatry 55 (6): 449-450
- Hotujac A, Sagud M, Hotujac Lj (2000) Drug use among Croatian students. Coll Antropol 24 (1): 61-68
Poglavlja u knjigama:
1) Marčinko D, Pivac N, Šagud M, Mück-eler D, Mihaljević-Peleš A, Jakovljević M (2011) Biološke osnove suicidalnog ponašanja. U: D. Marčinko i sur., Med. Naklada, Zagreb 2011., str. 62-81
2) Sagud M, Mihaljević-Peleš A (2006) Psihofarmakologija. U: Suradna i konzultativna psihijatrija, R. Gregurek i sur., Šk. knjiga, Zagreb, 2006., str. 193-225
3) Sagud M, Mihaljević-Peleš A (2006) Ginekologija i opstetricija U: Suradna i konzultativna psihijatrija, R. Gregurek i sur., Šk. knjiga, Zagreb, 2006., 132-139
4) Mück-eler D, Pivac N, Sagud M, Mustapić M, Jakovljevi M (2005) The effects of serotonin uptake inhibitors on platelet serotonin: From basic to clinical research. U: Trends in serotonin uptake inhibitor research: 29-53
5) Hotujac Lj, Sagud M (2001) Resorpcija, metabolizam i eliminacija benzodiazepina. U: Jakovljevic M and Lackovic Z: Benzodiazepini u suvremenoj medicini: 72-78
6) Hotujac Lj, Sagud M (2000) Benzodiazepini. U: Durakovic Z i sur: Klinička toksikologija., Grafos, Zagreb, 2000: 345-349
Ostali radovi:
1) Sagud M, Mihaljević-Peleš A, Begić D, Vuksan-Ćusa B, Kramarić M, Zivković M, Jakovljević M (2011) Antipsychotics as antidepressants: what is the mechanism? Psychiatr Danub 23(3):302-7.
2) Mihaljević-Peleš A, Sagud M, Janović MB, Mikulić SK, Jevtović S (2011) Do we need new therapeutic strategies for depression? Psychiatr Danub 23(3):300-1
3) Mihaljević-Peles A, Sagud M, Bozina N, Zivković M, Jovanović N (2010) Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy. Psychiatr Danub 22(2):335-7.
4) Vuksan-Cusa B, Sagud M, Jakovljević M (2010) C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia. Psychiatr Danub 22(2):275-7.
5) Sagud M, Mück-Seler D, Mihaljević-Peles A, Vuksan-Cusa B, Zivković M, Jakovljević M, Pivac N (2010) Catechol-O-methyl transferase and schizophrenia. Psychiatria Danubina 22(2):270-4
6) Sagud M, Mihaljević-Peles A, Mück-Seler D, Pivac N, Vuksan-Cusa B, Brataljenović T, Jakovljević M (2009) Smoking and schizophrenia. Psychiatr Danub 21(3):371-5
7) Zivković M, Mihaljević-Peles A, Sagud M, Silić A, Mihanović M. The role of CYP2D6 and TaqI A polymorphisms in malignant neuroleptic syndrome: two case reports with three episodes. Psychiatr Danub. 2010 Mar;22(1):112-6
8) Mihaljević-Peles A, Sagud M, Bozina N, Zivković M, Jovanović N. Pharmacogenetics and interactions of antidepressants in the treatment of co-morbid illness. Psychiatr Danub. 2009 Sep;21(3):399-400
9) Vuksan-Cusa B, Marcinko D, Sagud M, Jakovljević M. The comorbidity of bipolar disorder and cardiovascular diseases from pharmacotherapy perspective. Psychiatr Danub. 2009 Sep;21(3):382-5
10) Sagud M, Mihaljević-Peles A, Mück-Seler D, Pivac N, Vuksan-Cusa B, Brataljenović T, Jakovljević M. Smoking and schizophrenia. Psychiatr Danub. 2009 Sep;21(3):371-375
11) Sagud M, Mihaljević-Peles A, Pivac N, Muck-Seler D, Simunović I, Jakovljević M. Genetics of schizophrenia in the context of integrative psychiatry. Psychiatr Danub. 2008 Sep;20(3):364-8.
12) Mihaljević-Peles A, Sagud M, Bozina N, Zivković M. Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective. Psychiatr Danub. 2008 Sep;20(3):399-401.
13) Mihaljević-Peles A, Bozina N, Sagud M. Pharmacogenetics in modern psychiatry. Psychiatr Danub. 2007 Sep;19(3):231-3.
14) Bozina N, Mihaljevic-Peles A, Sagud M, Jakovljevic M, Sertic J. Serotonin transporter polymorphism in Croatian patients with major depressive disorder. Psychiatr Danub. 2006 Jun;18(1-2):83-9.
15) Sagud M, Mihaljevic-Peles A, Jakovljevic M (2002) Selektivni inhibitori ponovne pohrane serotonina. Medicus 11(2): 165-170
16) Mihaljević-Peleš A, Šagud M, Jakovljević M (2002) Antiepileptici kao stabilizatori raspoloženja. Medicus 11 (2): 171-175
17) Jakovljević M, Mihaljević-Peleš A, Šagud M (2002) Prirodni lijekovi u terapiji mentalnih poremećaja. Medicus 11 (2): 263-169
18) Šagud M, Jakovljević M, Mihaljević-Peleš A, Tomić D, Di Cesare F (1999) Agranulocytosis after addition of risperidone to clozapine treatment-a case report. Psychiatria Danubina 11 (3-4): 153-158
19) Šagud M, Hotujac Lj (1996) Prikaz bolesnice s afonijom (neophodnost stručnog konzilija). Socijalna psihijatrija 24 (2-3): 104-107
20) Hotujac Lj, Šagud M (1995) Racionalna primjena benzodiazepina. Pharmaca 33 (1-2): 47-59
21) Šagud M, Jakovljević M, Mihaljević-Peleš A, Medved V (1995) Pharmacokinetic opitimisation of lithium treatment. Psychiatria Danubina 3-4 (7): 169-173
22) Šagud M, Klinar I, Schönwald S, Baršić B (1994) Kliničko istraživanje podnošljivosti azitromicina u djece. Pharmaca 32 (1): 57-66
23) Baršić B, Schönwald S, Klinar I, Šagud M, Šušković T (1994) Comparison of three-day azithromycin and ten-day cefaclor in the treatment of patients with lower respiratory tract infection. Pharmaca 32: 137-146
Name: MARINA ŠAGUD
Business address:Department of Psychiatry,
UniversityHospital “Rebro”, Kišpatićeva 12, 1000 Zagreb, Croatia Phone: 385 1 23 88 353 Fax: 385 1 23 88 329 e-mail: marinasagud@mail.com |
Title: MD, specialist in psychiatry
EDUCATION:
Primary school, secondary school completed in Zagreb,
1988-Graduated from the School of Medicine, University of Zagreb
1992 – completed postgraduate study of clinical pharmacology, at the School of Medicine, University of Zagreb
1993-1997-Residency in psychiatry performed at the University Hospital Center Zagreb, Department of Psychiatry
2001-2003-attended PhD program at the School of Medicine, University of Zagreb
PhD degree-April, 2007
EMPLOYMENT:
- Pharmaceutical company “Pliva” (dealing with the clinical trials of antimycrobial agents)
- Department of Psychiatry, UniversityHospital “Rebro”, Zagreb (for the last 19 years)
FIELD OF PROFESSIONAL ACTIVITIES:
A rich experience in treatment of psychotic patients with schizophrenia, schizoaffective and affective disorders, as well as with PTSD. Conducting the treatment of both in- and out-patients, working at the emergency unit. Extensively involved in clinical trials. Actively participated in numerous congresses.
FIELD OF PROFESSIONAL INTEREST:
Pharmacogenomics
Psychopharmacology